Related Experiment Video
Updated: Jun 30, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
A Nomogram Based on the Castelli Risk Index for Predicting Prognosis in Patients With Acute Coronary Syndrome
Yan Liu1, Ge Song1, Ying Zhang1,2,3
1Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Insights
Castelli's risk indices (CRI-I and CRI-II) predict major adverse cardiovascular events (MACEs) in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). Higher CRI values indicate increased risk, aiding in prognosis assessment.
Area of Science:
- Cardiology
- Clinical Lipidology
- Interventional Cardiology
Background:
- Composite lipid indices are linked to disease risk and prognosis.
- No prior studies investigated Castelli's risk indices (CRI-I, CRI-II) in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI).
Purpose of the Study:
- To evaluate the prognostic value of CRI-I and CRI-II in patients with ACS undergoing PCI.
- To determine the association between CRI-I, CRI-II, and major adverse cardiovascular events (MACEs).
Main Methods:
- Prospective cohort study of 1475 ACS patients undergoing PCI (January 2016 - December 2018).
- Measurement of CRI-I and CRI-II.
- Follow-up for MACEs (all-cause mortality, heart failure rehospitalization, myocardial infarction recurrence, in-stent restenosis, repeat PCI) at regular intervals.
Main Results:
- Multivariable Cox regression showed increased MACE risk with higher CRI-I and CRI-II.
- Significantly lower cumulative survival rates for patients with CRI-I ≥ 3.350 and CRI-II ≥ 1.697 (log-rank tests, p < 0.001).
- A nomogram demonstrated good predictive performance for 1-, 2-, and 3-year survival probabilities.
Conclusions:
- Elevated CRI-I (≥ 3.350) and CRI-II (≥ 1.697) are independent predictors of MACEs.
- These indices can aid in risk stratification for ACS patients undergoing PCI.
Background And Aims:
Composite lipid indices are closely related to the risk and poor prognosis of diseases. However, there are no studies on the prognostic value of Castelli's risk indices-I and II (CRI-I, CRI-II) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Therefore, the aim of this study was to investigate the association of CRI-I and CRI-II with the prognosis of patients with ACS undergoing PCI.
Patients And Methods:
A total of 1475 patients with ACS undergoing PCI were consecutively enrolled in this prospective cohort study from January 2016 to December 2018. The CRI-I and CRI-II were measured. The endpoints were MACEs, including all-cause mortality, requirement of rehospitalization for severe heart failure, recurrence of myocardial infarction, in-stent restenosis, and reaccept PCI. Follow-up data were collected via clinical visits or telephone calls at 1, 3, 6, and 12 months and annually thereafter.
Result:
Multivariable Cox regression analysis revealed that the risk of MACEs increased gradually with increasing CRI-I and CRI-II. The cumulative survival rate in the CRI-I ≥ 3.350 and CRI-II ≥ 1.697 groups was significantly lower than that in the CRI-I < 3.350 and CRI-II < 1.697 groups, respectively (log-rank tests: all p < 0.001). The nomogram demonstrated good predictive performance for the 1-, 2-, and 3-year survival probability.
Conclusions:
CRI-I ≥ 3.350 and CRI-II ≥ 1.697 could serve as independent predictors of MACEs in patients with ACS undergoing PCI.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

